Levofloxacina Bruschettini

Levofloxacin, the active ingredient in Levofloxacina Bruschettini, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial eye infections such as conjunctivitis and keratitis in adults and children as prescribed.

GNH USA supplies Levofloxacina Bruschettini as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacina Bruschettini is a fluoroquinolone used to manage bacterial infections of the eye and related ocular tissues.

- Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of infection. - Bacterial keratitis: eradicates causative organisms and supports corneal healing. - Post‑operative ocular infection: prevents bacterial proliferation and aids recovery. - Other ocular bacterial infections: controls infection and reduces risk of complications.

Levofloxacina Bruschettini may cause ocular and systemic reactions.

Common Side Effects: - Eye irritation or burning sensation. - Redness and tearing of the treated eye. - Transient blurred vision. - Mild allergic conjunctivitis.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling or difficulty breathing. - Corneal ulcer worsening or perforation. - Tendon rupture or musculoskeletal pain (systemic exposure). - Stevens‑Johnson syndrome or toxic epidermal necrolysis affecting the eye.

Use Levofloxacina Bruschettini with caution and follow professional guidance.

- Allergy assessment: avoid if known hypersensitivity to fluoroquinolones. - Pregnancy and lactation: use only when benefits outweigh potential risks. - Contact lens wearers: remove lenses before administration and wait before reinserting. - Concurrent systemic fluoroquinolone therapy: monitor for additive toxicity. - Store at room temperature: keep in original container, protect from light and moisture.

Levofloxacina Bruschettini can interact with other ophthalmic and systemic agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: increased risk of tendon toxicity. - Corticosteroid eye drops: may delay corneal healing. - Anticholinergic ophthalmic agents: may reduce drug absorption.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: possible additive ocular irritation. - Herbal supplements containing quinine: potential additive QT‑interval prolongation.